Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Sobriety restrictions on hepatitis C treatments hinder our ability to properly address the viral hepatitis and overdose syndemic.
The White House strategy embraces syringe services, access to housing and naloxone as three science-based approaches.
Now that the dam has broken, it may not be long before additional overdose prevention centers open around the country.
Co-occurring health disorders appear to contribute to increased risk, NIH study suggests.
A $6.6 million grant aims to integrate services for HIV, hepatitis B and C and substance misuse into primary care clinics across the state.
Areas with lower population density have not seen the same slowdown as urban areas.
Researchers found that longer usage of injection drugs was positively linked to hep C testing.
Requiring sobriety prior to treatment and curtailing harm reduction hinder efforts to eliminate hep C.
People with an opioid use disorder, in particular, had a tenfold higher risk of being diagnosed with COVID-19.
A recent opinion piece in the Columbia Journalism Review argues that the distinction matters.
State officials have issued a public health alert for those experiencing homelessness, addiction and/or substance use disorders.
Alcohol use, smoking and unhealthy diets contribute to mortality risk in HCV-positive patients as much as the virus itself.
Linkage to care is more than giving someone a positive hepatitis C (HCV) test result and sending them on their way.
Promising results in studies are tempered by myriad barriers against successfully treating and curing the disease in real world settings.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.